EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases

Ugnė Šinkevičiūtė iD, Kateřina Burgetová Ječmeňová iD, Soňa Gurská iD, Lenka Poštová Slavětínská, Vincent Baran, Pavel Polishchuk iD, Petr Džubák iD, Michal Hocek iD, Marián Hajdúch, Michal Tichý iD

ChemMedChem · 2026

DOI: 10.1002/cmdc.70419 ↗

At a glance

Journal article in ChemMedChem, 2026. Written by Ugnė Šinkevičiūtė and 9 co-authors. Institution: Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, Czech Republic. Major MEDLINE topics: Purines, Antineoplastic Agents, Purinergic P1 Receptor Antagonists. 38 references. The full text is freely available (open access, CC BY 4.0). Funded by: Ministerstvo Školství, Mládeže a Tělovýchovy.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

High‐throughput screening of the IMTM compound library for modulatory activity on adenosine receptors (ARs) identified two deazapurine hits based on 2,6‐diaryl‐7‐deazapurines. In this study, a series of 16 new 2,6‐diaryl‐7‐deazapurine nucleobases together with four N‐9 substituted derivatives were synthesized. The synthesis was based on regioselective Suzuki cross‐coupling into position 6 followed by a second Suzuki cross‐coupling at position 2 under harsher conditions. Both cross‐couplings were performed on N‐9 protected nucleobases. Biological activity profiling identified several potent antagonists of all four subtypes of ARs and four compounds as sub‐micromolar and very selective antagonists of A 3 . Several final compounds showed potent in vitro cytotoxic activity on a small panel of cancer cell lines, but with no selectivity against nonmalignant fibroblasts BJ and MRC‐5.

Subjects

MeSH terms (MEDLINE)

PurinesAntineoplastic AgentsPurinergic P1 Receptor AntagonistsHumansStructure-Activity RelationshipCell Line, TumorMolecular StructureReceptors, Purinergic P1Dose-Response Relationship, DrugDrug Screening Assays, Antitumor

Author keywords

7‐deazapurineSuzuki cross‐couplingadenosine receptor antagonist

Substances

Purines7-deazapurineAntineoplastic AgentsReceptors, Purinergic P1Purinergic P1 Receptor Antagonists

Authors and institutions

  • Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, Czech Republic.
  • Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Prague 2, Czech Republic.
  • Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc, Olomouc, Czech Republic.

ORCID profiles: Ugnė Šinkevičiūtė, Kateřina Burgetová Ječmeňová, Soňa Gurská, Pavel Polishchuk, Petr Džubák, Michal Hocek, Michal Tichý

Funding

  • Ministerstvo Školství, Mládeže a Tělovýchovy

Cite

APA

Šinkevičiūtė, U., Burgetová Ječmeňová, K., Gurská, S., Poštová Slavětínská, L., Baran, V., Polishchuk, P., Džubák, P., Hocek, M., Hajdúch, M., & Tichý, M. (2026). Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases. ChemMedChem. https://doi.org/10.1002/cmdc.70419

Vancouver

Šinkevičiūtė U, Burgetová Ječmeňová K, Gurská S, Poštová Slavětínská L, Baran V, Polishchuk P, et al. Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases. ChemMedChem. 2026. doi:10.1002/cmdc.70419

BibTeX
@article{inkeviit2026,
  author = {Šinkevičiūtė, Ugnė and Burgetová Ječmeňová, Kateřina and Gurská, Soňa and Poštová Slavětínská, Lenka and Baran, Vincent and Polishchuk, Pavel and Džubák, Petr and Hocek, Michal and Hajdúch, Marián and Tichý, Michal},
  title = {Synthesis and Biological Activity of 2,6‐Disubstituted and 2,6,9‐Trisubstituted 7‐Deazapurine Nucleobases},
  journal = {ChemMedChem},
  year = {2026},
  doi = {10.1002/cmdc.70419}
}
Start for free →